60 related articles for article (PubMed ID: 2057701)
1. [Evaluation of osteoclastic activity in multiple myeloma: results of a randomized trial studying hypocalcemia induced by human and salmon calcitonin in 49 patients].
Fuzibet JG; Lejeune C; Lepeu G; Jaubert J; Sotto JJ; Peyron R
Rev Rhum Mal Osteoartic; 1991 Mar; 58(3):223-7. PubMed ID: 2057701
[TBL] [Abstract][Full Text] [Related]
2. Calcitonin resistance: clinical and immunologic studies in subjects with Paget's disease of bone treated with porcine and salmon calcitonins.
Haddad JG; Caldwell JG
J Clin Invest; 1972 Dec; 51(12):3133-41. PubMed ID: 4674398
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of salmon calcitonin in multiple myeloma: a valuable method for serial evaluation of osteoclastic lesions and disease activity--a prospective study of 125 patients.
Bataille R; Legendre C; Sany J
J Clin Oncol; 1985 Feb; 3(2):229-36. PubMed ID: 3968553
[TBL] [Abstract][Full Text] [Related]
4. [The hypocalcemia test, using human and salmon synthetic calcitonins. Paradoxical hypercalcemic responses. Responses in patients with Paget's disease treated with EHDP].
Alexandre C; Chapuy MC; Meunier P
Rev Rhum Mal Osteoartic; 1979 May; 46(5):335-42. PubMed ID: 116360
[TBL] [Abstract][Full Text] [Related]
5. [Dynamic test of hypocalcemia induced by calcitonin as a mean of global evaluation of osteoclastic activity in vivo. A new method of interpretation and results in the breakdown of osteoporosis].
Colson F; Gioud M; Tebib JG; Mathieu M; Bouvier M
Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):481-6. PubMed ID: 3616473
[No Abstract] [Full Text] [Related]
6. [Induced hypocalcaemia test using salmon calcitonin as a means for the evaluation of osteoclastic activity (author's transl)].
Blanc D; Chapuy MC; Meunier P
Nouv Presse Med; 1977 Aug 27-Sep 3; 6(28):2489-94. PubMed ID: 562508
[TBL] [Abstract][Full Text] [Related]
7. [Asu(1,7)E-CT, an analog of eel calcitonin. A comparative study in man with reference to other synthetic calcitonins].
Caniggia A; Nuti R; Vattimo A; Galli M; Turchetti V; Franci B; Martorelli T; Righi G
Minerva Med; 1983 Apr; 74(18):993-1010. PubMed ID: 6087215
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of myeloma osteoclastic bone lesions: II. Induced hypocalcemia test using salmon calcitonin.
Bataille R; Sany J
Metab Bone Dis Relat Res; 1982; 4(1):39-42. PubMed ID: 7121253
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness of synthetic calcitonin derivative (elcatonin) on the bone pain and serum calcium concentration in multiple myeloma].
Hirota Y; Kondou S; Okamura H; Ikematsu W; Aso T; Kounoue E; Matsumoto I; Kuwashima K; Kajiyama K
Gan To Kagaku Ryoho; 1990 May; 17(5):1059-63. PubMed ID: 2334172
[TBL] [Abstract][Full Text] [Related]
10. Platypus and opossum calcitonins exhibit strong activities, even though they belong to mammals.
Yamashita T; Udagawa N; Thirukonda GJ; Uehara S; Yamauchi H; Suzuki N; Li F; Kobayashi Y; Takahashi N
Gen Comp Endocrinol; 2017 May; 246():270-278. PubMed ID: 28062306
[TBL] [Abstract][Full Text] [Related]
11. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P
Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of safety and efficacy of pamidronate and zoledronic acid in multiple myeloma patients (single center experience).
Kraj M; Pogłód R; Maj S; Pawlikowski J; Sokołowska U; Szczepanik J
Acta Pol Pharm; 2002; 59(6):478-82. PubMed ID: 12669777
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin of the stingray: comparison of the hypocalcemic activity with other calcitonins.
Sasayama Y; Suzuki N; Oguro C; Takei Y; Takahashi A; Watanabe TX; Nakajima K; Sakakibara S
Gen Comp Endocrinol; 1992 May; 86(2):269-74. PubMed ID: 1601276
[TBL] [Abstract][Full Text] [Related]
14. Hypocalcemia response following calcitonin administration: lack of correlation with osteoclast number determined after histoenzymologic identification in osteoporosis.
Palle S; Chappard D; Vico L; Alexandre C
Clin Rheumatol; 1988 Sep; 7(3):354-8. PubMed ID: 3229081
[TBL] [Abstract][Full Text] [Related]
15. Metabolic effects of carbocalcitonin and salmon calcitonin, after endonasal administration in man.
Cecchettin M; Segre G
Biomed Pharmacother; 1995; 49(4):215-8. PubMed ID: 7669941
[TBL] [Abstract][Full Text] [Related]
16. Induction of acute hypocalcemia in rats.
Puerro M; Aleixandre MA; Hernandez R
Vet Hum Toxicol; 1995 Apr; 37(2):116-7. PubMed ID: 7631490
[TBL] [Abstract][Full Text] [Related]
17. Antalgic activity of calcitonin: effectiveness of the epidural and subarachnoid routes in man.
Fiore CE; Castorina F; Malatino LS; Tamburino C
Int J Clin Pharmacol Res; 1983; 3(4):257-60. PubMed ID: 6689594
[TBL] [Abstract][Full Text] [Related]
18. Circulating angiogenic cytokines in multiple myeloma and related disorders.
Urba ska-Rys H; Wierzbowska A; Robak T
Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
[TBL] [Abstract][Full Text] [Related]
19. The effect of calcitonin on biochemical markers and zinc excretion in postmenopausal osteoporosis.
Colpan L; Gur A; Cevik R; Nas K; Sarac AJ
Maturitas; 2005 Jul; 51(3):246-53. PubMed ID: 15978968
[TBL] [Abstract][Full Text] [Related]
20. Salmon calcitonin induced hypocalcemia and hyperphosphatemia in an elasmobranch, Dasyatis akajei.
Srivastav AK; Srivastav SK; Sasayama Y; Suzuki N
Gen Comp Endocrinol; 1998 Jan; 109(1):8-12. PubMed ID: 9446717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
